InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Reid Laurence, Chairman & CEO. Director active across 1 companies, notably Decibel Therapeutics, Inc.. Cumulatively, 2 filings have been logged. Total volume traded: €129k. The latest transaction was disclosed on 15 September 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€64,63610,000 shares@ €6.4636100.0% of flow
Common Stock
SEC:0000899243-21-036500·
Ideal exit: 12 Jun 2022 (T+270)
€64,63610,000 shares@ €6.463650.0% of flow
Common Stock
SEC:0000899243-21-036500:0·
Ideal exit: 12 Jun 2022 (T+270)
2 of 2 declarations
About Reid Laurence
Laurence Reid is the President and Chief Executive Officer of Decibel Therapeutics, Inc. He is responsible for the strategic and operational direction of the company, which focuses on developing hearing treatments. Reid is committed to advancing Decibel's mission.
